Methods for rapid detection of egfr variants and amplification
OwnerDeeksha Saxena, Jay F. Dorsey +2inventors
InventorsDeeksha Saxena, Jay F. Dorsey, Gary D. Kao, Donald O'Rourke
Life of this patent
Estimating the term…
Abstract
Provided herein are methods and compositions for detecting EGFR amplification and the presence of EGFR variants in a biological sample.
Claims17
A method of detecting epidermal growth factor receptor - variant III (EGFRvIII), the method comprising generating a cDNA sample from RNA present in a biological sample, contacting the cDNA sample with a forward primer that binds EGFR exon 1, a reverse primer that binds EGFR exon 8, and a minor groove binder (MGB) probe comprising an oligonucleotide having at least the sequence of:
- 5′ AAA GGT AAT TAT 3′ (SEQ ID NO:
- 3) that binds the junction of EGFR exons 1 and 8, and performing digital PCR in order to detect EGFRvIII.
A method of detecting EGFR, the method comprising generating a cDNA sample from RNA present in a biological sample, further comprising contacting the cDNA sample with a forward primer that binds EGFR exon 5, a reverse primer that binds EGFR exon 6, and a MGB probe comprising an oligonucleotide having at least the sequence of:
- 5′ AGG AGA ACT GCC 3′ (SEQ ID NO:
- 6) that binds the junction of EGFR exons 5 and 6, and performing digital PCR in order to detect wildtype EGFR.
A method for treating a cancer characterized by expression of epidermal growth factor receptor—variant III (EGFRvIII), the method comprising generating a cDNA sample from RNA present in the biological sample, contacting the cDNA sample with a forward primer that binds EGFR exon 1, a reverse primer that binds EGFR exon 8, and a MGB probe having an oligonucleotide comprising at least the sequence of:
- 5′ AAA GGT AAT TAT 3′ (SEQ ID NO:
- 3) that binds the junction of EGFR exon 1 and 8, and performing digital PCR in order to detect the EGFRvIII, wherein the presence of amplified sequences indicates a cancer associated with EGFRvIII, and treating the subject for the cancer.
Dependencies are inferred from the claim text.